Soraa’s Lighting Brings Sophistication and Warmth to Seaside City Restaurant
Soraa, the world leader in GaN on GaNTM LED technology, announced that its LED lamps have been installed in the MaNCaR Restaurant in the seaside neighborhood of Alsancak in Izmir, Turkey. MaNCaR is a unique, sophisticated restaurant that attracts both locals and tourists looking for a high-end dining experience, delivering impeccably prepared food and an enchanting ambiance.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160406006514/en/
The owners of the MaNCaR restaurant worked with interior designers at Toner Architects and lighting designers at PLANLUX, who chose Soraa’s VIVID LED MR16s to light the space. This selection provides tremendous dimming and control flexibility allowing them to not only adjust the level of light as needed but also adapt to changes in the table configurations. Soraa’s MR16 lamps give the restaurant the ability to have a dimmable, narrow beam solution spotlight the tables, creating a tasteful glimmer on the food and wine without disturbing the guests. And not only is the lighting beautiful, but the new lamps will lower energy use and costs for the restaurant.
“When it comes to quality of light with required beam widths, and filtering abilities, Soraa’s products outshine the competition. Soraa lamps deliver simply perfect lighting that enhances the customer experience,” said Korhan Şişman, light designer at PLANLUX.
"An unorthodox take on restaurant concept with a pure and modernistic architecture, Mancar was designed in a way so it could be a laid back, unexposed and natural restaurant that did not outshine the food it serves," said Mustafa Toner, Toner Architecture.
Soraa’s unique GaN on GaN™ technology allows its LEDs to operate at currents that are more than five times higher than LEDs built on other materials. This means a lot of light comes from a very small source, resulting in a narrow beam that can be controlled to crisply illuminate any area with a single shadow.
The MaNCaR bar and seating areas are illuminated for perfect rendering of colours and whiteness because of Soraa’s Violet-Emission 3-Phosphor (VP₃) LED technology. Utilizing every color in the rainbow, especially deep red emission, Soraa’s lamps render warm tones beautifully and accurately, and achieve a colour-rendering index (CRI) of 95 and deep red (R9) rendering of 95. And unlike blue-based white LEDs without any violet emission, the company’s lamps have violet emissions to properly excite fluorescing brightening agents, including paper and natural objects like human eyes and teeth.
For more information on Soraa’s LED lamps, please visit: www.soraa.com .
Pioneering lamps using LEDs built from pure gallium nitride substrates (GaN on GaN™), Soraa has made ordinary lighting extraordinarily brilliant and efficient. Soraa’s full spectrum GaN on GaN™ LED lamps have superior colour rendering and beam characteristics compared to lamps using LEDs created from non-native substrates. Founded in 2008, Soraa is located in Fremont California, where it manufactures its GaN on GaN™ LEDs in the company’s state-of-the-art facility. For additional information, please visit www.soraa.com and follow the company on Twitter , LinkedIn and Facebook .
Andy Beck, 001-202-587-5634
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skrive dig op her og du vil løbende modtage pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
ADC-THERAPEUTICS11.12.2017 07:32 | pressemeddelelse
ADC Therapeutics Announces Interim Phase I Data from its Novel Antibody-Drug Conjugate ADCT-301
ADC-THERAPEUTICS11.12.2017 07:02 | pressemeddelelse
ADC Therapeutics Presents Interim Phase I Data from its Novel Antibody-Drug Conjugate ADCT-402
FL-GA-TELESIS11.12.2017 06:03 | pressemeddelelse
GA Telesis Launches Leveraged Finance Group with the Appointments of David Lloyd and Nolan Heske
ASTRAZENECA10.12.2017 23:47 | pressemeddelelse
AstraZeneca’s Calquence (acalabrutinib) Shows Potential in Chronic Lymphocytic Leukaemia Trials
NJ-CELGENE/BLUEBIRD-BIO10.12.2017 16:32 | pressemeddelelse
Celgene Corporation and bluebird bio Announce Updated Results from Ongoing Multicenter Phase 1 Study of bb2121 Anti-BCMA CAR T Cell Therapy in Patients with Late Stage Relapsed/Refractory Multiple Myeloma at ASH Annual Meeting
GA-GILEAD-SCIENCES/KITE10.12.2017 16:32 | pressemeddelelse
Kite Announces Long-Term Data From Pivotal ZUMA-1 Study of Yescarta™ (Axicabtagene Ciloleucel) in Patients With Refractory Large B-cell Lymphoma
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum